Weibo Announces Results of 2026 Annual General Meeting
Shareholders approved the re-election of Charles Guowei Chao, Gaofei Wang and Pochin Christopher Lu at the company’s annual meeting.
- On Wednesday, May 27, 2026, Weibo and Kneat held their respective Annual General Meetings, where shareholders voted to re-elect their director slates and finalize leadership oversight.
- Weibo shareholders adopted resolutions to re-elect Charles Guowei Chao, Gaofei Wang, and Pochin Christopher Lu as directors, who will retain their positions until retirement pursuant to the company's articles.
- Kneat shareholders elected all five board nominees, with 51,419,056 votes cast and KPMG LLP receiving 99.99% support for re-appointment as auditors at the 2026 AGM.
- Final voting outcomes for the 2026 AGM have been filed with Canadian securities regulators, according to Kneat, providing detailed results for both director elections and auditor re-appointment.
- Weibo continues to operate its social media platform in China, while Kneat supports highly regulated industries with its digital validation platform, both strengthened by renewed board leadership.
11 Articles
11 Articles
The Hamilton Spectator
Kneat Announces Results of Voting at Annual General Meeting
LIMERICK, Ireland, May 27, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) (“Kneat” or the “Company”), a leader in digitizing and automating validation and quality processes, announced results from its Annual General Meeting of Shareholders (the “2026 AGM”),…
Weibo Announces Results of 2026 Annual General Meeting
BEIJING, May 27, 2026 /PRNewswire/ -- Weibo Corporation ("Weibo" or the "Company") (NASDAQ: WB and HKEX: 9898), a leading social media in China, today announced that the following proposed resolutions submitted for shareholder approval as set forth in the notice…
The Caledonian Record
ADKhabarAgomab Announces Results of Annual General Meeting
Antwerp, Belgium, May 27, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced the results of its Annual General Meeting (AGM) held on Tuesday, May 26, 2026.
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
